ALEXION PHARMACEUTICALS, INC.

Lobbying client · Massachusetts · filed 2025 to 2025

Biopharmaceutical Company.

$160,000 Reported spend

2 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 2 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (205224), not by name.

Firms hired 1

TODD STRATEGY GROUP $160,000 2 filings

Bills named in these filings 3

HR 1672
Maintaining Investments in New Innovation Act

2 filings
HR 946
ORPHAN Cures Act

2 filings
S 864
HELP Copays Act

2 filings

Reported by year 1 year

2025 $160,000 2 filings

Issues lobbied 2

Health Issues 2
Medicare/Medicaid 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Centers For Medicare and Medicaid Services (CMS) 2
Health & Human Services, Dept of (HHS) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2
White House Office 2

Recent filings 3 total

2T

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $80,000 income · posted Oct 14, 2025

View → Q2

TODD STRATEGY GROUP Amended

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $80,000 income · posted Jul 19, 2025

View → Q1

TODD STRATEGY GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $80,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.